4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-25-001026
Chief Scientific Officer sold 9,215 shares at an average $30.04 ($276,776)
- Chief Scientific Officer acquired 9,215 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/primarydocument.xml…